Pullen Investment Management LLC increased its stake in American Vanguard Co. (NYSE:AVD - Free Report) by 119.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 178,242 shares of the basic materials company's stock after purchasing an additional 97,099 shares during the quarter. Pullen Investment Management LLC owned about 0.62% of American Vanguard worth $825,000 at the end of the most recent quarter.
Several other institutional investors have also bought and sold shares of AVD. PNC Financial Services Group Inc. lifted its holdings in American Vanguard by 133.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 6,575 shares of the basic materials company's stock worth $30,000 after purchasing an additional 3,753 shares during the period. Intech Investment Management LLC acquired a new stake in American Vanguard in the fourth quarter worth about $50,000. Ieq Capital LLC acquired a new stake in American Vanguard in the fourth quarter worth about $54,000. Bayesian Capital Management LP acquired a new stake in American Vanguard in the fourth quarter worth about $54,000. Finally, Susquehanna Fundamental Investments LLC acquired a new stake in American Vanguard in the 4th quarter valued at about $68,000. Institutional investors and hedge funds own 79.04% of the company's stock.
American Vanguard Price Performance
NYSE AVD traded up $0.03 on Thursday, reaching $4.45. The company's stock had a trading volume of 163,182 shares, compared to its average volume of 267,794. American Vanguard Co. has a twelve month low of $3.28 and a twelve month high of $9.84. The company has a debt-to-equity ratio of 0.55, a quick ratio of 0.79 and a current ratio of 1.89. The stock has a market cap of $127.96 million, a PE ratio of -4.32 and a beta of 1.24. The firm's 50 day moving average is $4.13 and its two-hundred day moving average is $4.89.
American Vanguard Company Profile
(
Free Report)
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Featured Stories

Before you consider American Vanguard, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Vanguard wasn't on the list.
While American Vanguard currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.